12:00 AM
 | 
Sep 13, 2010
 |  BC Week In Review  |  Company News  |  Management Tracks

BioTime management update

BioTime Inc. (NYSE-A:BTIM), Alameda, Calif.
Business: Hematology, Gene/Cell therapy
Resigning: Steven Seinberg...

Read the full 37 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >